Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARVIND REMEDIES vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ARVIND REMEDIES SUN PHARMA ARVIND REMEDIES/
SUN PHARMA
 
P/E (TTM) x -0.2 38.7 - View Chart
P/BV x - 6.8 - View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 ARVIND REMEDIES   SUN PHARMA
EQUITY SHARE DATA
    ARVIND REMEDIES
Jun-15
SUN PHARMA
Mar-24
ARVIND REMEDIES/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs661,634 4.0%   
Low Rs10923 1.1%   
Sales per share (Unadj.) Rs115.5202.1 57.1%  
Earnings per share (Unadj.) Rs-47.040.2 -116.8%  
Cash flow per share (Unadj.) Rs-42.650.9 -83.8%  
Dividends per share (Unadj.) Rs013.50 0.0%  
Avg Dividend yield %01.1 0.0%  
Book value per share (Unadj.) Rs-6.2265.4 -2.3%  
Shares outstanding (eoy) m68.142,399.34 2.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.36.3 5.2%   
Avg P/E ratio x-0.831.8 -2.5%  
P/CF ratio (eoy) x-0.925.1 -3.5%  
Price / Book Value ratio x-6.14.8 -127.2%  
Dividend payout %033.6 -0.0%   
Avg Mkt Cap Rs m2,5913,067,070 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m16094,291 0.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,871484,969 1.6%  
Other income Rs m5916,282 0.4%   
Total revenues Rs m7,929501,251 1.6%   
Gross profit Rs m-2,306122,548 -1.9%  
Depreciation Rs m29525,566 1.2%   
Interest Rs m7112,385 29.8%   
Profit before tax Rs m-3,253110,879 -2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-5214,395 -0.4%   
Profit after tax Rs m-3,20096,484 -3.3%  
Gross profit margin %-29.325.3 -115.9%  
Effective tax rate %1.613.0 12.4%   
Net profit margin %-40.719.9 -204.4%  
BALANCE SHEET DATA
Current assets Rs m5,001434,331 1.2%   
Current liabilities Rs m5,918169,838 3.5%   
Net working cap to sales %-11.754.5 -21.4%  
Current ratio x0.82.6 33.0%  
Inventory Days Days4135 2.9%  
Debtors Days Days2,21485 2,615.4%  
Net fixed assets Rs m2,837378,843 0.7%   
Share capital Rs m6812,399 28.4%   
"Free" reserves Rs m-1,104634,268 -0.2%   
Net worth Rs m-423636,668 -0.1%   
Long term debt Rs m1,93813 14,567.9%   
Total assets Rs m7,838813,592 1.0%  
Interest coverage x-3.647.5 -7.5%   
Debt to equity ratio x-4.60 -21,938,937.3%  
Sales to assets ratio x1.00.6 168.5%   
Return on assets %-31.812.2 -261.4%  
Return on equity %757.015.2 4,995.3%  
Return on capital %-167.817.8 -943.4%  
Exports to sales %0.30-   
Imports to sales %00-   
Exports (fob) Rs m27NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27142,683 0.0%   
Fx outflow Rs m062,932 0.0%   
Net fx Rs m2779,752 0.0%   
CASH FLOW
From Operations Rs m-1,512121,350 -1.2%  
From Investments Rs m1,050-6,902 -15.2%  
From Financial Activity Rs m439-67,102 -0.7%  
Net Cashflow Rs m-2346,619 -0.0%  

Share Holding

Indian Promoters % 3.6 54.5 6.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 36.6 0.1%  
FIIs % 0.0 18.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 96.4 45.5 211.8%  
Shareholders   71,277 657,317 10.8%  
Pledged promoter(s) holding % 55.8 0.8 7,059.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ARVIND REMEDIES With:   DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    ZYDUS LIFESCIENCES    


More on ARVIND REMEDIES vs Sun Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ARVIND REMEDIES vs Sun Pharma Share Price Performance

Period ARVIND REMEDIES Sun Pharma S&P BSE HEALTHCARE
1-Day -4.86% 1.13% 1.23%
1-Month -10.82% -4.71% -0.24%
1-Year -64.58% 49.28% 43.62%
3-Year CAGR -45.48% 32.62% 20.35%
5-Year CAGR -32.03% 31.80% 26.24%

* Compound Annual Growth Rate

Here are more details on the ARVIND REMEDIES share price and the Sun Pharma share price.

Moving on to shareholding structures...

The promoters of ARVIND REMEDIES hold a 3.6% stake in the company. In case of Sun Pharma the stake stands at 54.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ARVIND REMEDIES and the shareholding pattern of Sun Pharma.

Finally, a word on dividends...

In the most recent financial year, ARVIND REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Sun Pharma paid Rs 13.5, and its dividend payout ratio stood at 33.6%.

You may visit here to review the dividend history of ARVIND REMEDIES, and the dividend history of Sun Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.